Abstract Selective internal radiation therapy (SIRT) using Yttrium-90 loaded glass microspheres injected in the hepatic artery is an emerging, minimally invasive therapy of liver cancer. A personalized intervention can lead to high concentration dose in the tumor, while sparing the surrounding parenchyma. We propose a computational model for patient-specific simulation of entire hepatic arterial tree, based on liver, tumors, and arteries segmentation on patient's tomography. Segmentation of hepatic arteries down to a diameter of 0.5 mm is semi-automatically performed on 3D cone-beam CT angiography. The liver and tumors are extracted from CT-scan at portal phase by an active surface method. Once the images are registered through an automatic multimodal registration, extracted data are used to initialize a numerical model simulating liver vascular network. The model creates successive bifurcations Costanza Simoncini simoncini.costanza@gmail.com 
Introduction
The hepato-cellular carcinoma (HCC) is the leading cause of primary liver malignancy throughout the world and is the fourth cause of mortality, with more than 500000 deaths per year [10] . Treatment options are limited [1] ; a tumor in an early stage can be treated by liver transplantation, resection or percutaneous ablation. Intermediate or advanced stage HCC are treated with chemotherapy. Radiotherapy could be administered as an adjuvant at any stage of an HCC. It is estimated that less than 15% of patients are candidates for surgery, 50% for non-surgical treatments and 35% for best supportive care [1] . The most limiting factors for chemotherapy are the development of drug resistance and its serious side effects [16] ; for radiotherapy, it is the risk of causing radiation-induced liver disease [11] . This is why it is important to develop local and regional treatments. The treatment we are interested in is a particular kind of radiotherapy, called selective internal radiation therapy (SIRT) [11] . It consists in the injection of millions of microspheres containing radioactive Yttrium-90, directly into the hepatic artery, through a catheter. Microspheres flow into the liver tumor via its own vascular network and get permanently lodged in its small vessels. Consequently, there is preferential delivery of microspheres to the tumor capillary bed, allowing for higher doses of radiation to be delivered to the tumor, relative to the surrounding non-tumor parenchyma.
Even if globally more efficient than other HCC therapies, this methodology still needs to be optimized in terms of time and cost, as well as personalization [10] . A numerical model of vessels and blood flow would help the physician in the choice of the best injection site and of the dose amount, by letting him test different scenarios and optimize tumor targeting. If the numerical model is accurate enough, the distribution of the microspheres in the liver can be predicted, and invasive clinical examinations can be avoided. In fact, microspheres distribution is currently predicted by the injection of an equivalent amount of 99m Tc-loaded proteins, whose behavior is however sometimes different from the one of microspheres. Blood and microspheres flow simulation have already been implemented on arteries geometries made of 3-5 bifurcations [4, 5] . Knowing the geometry of the entire arterial tree of the patient seems to be necessary, and angiographic imagery can provide this information only at a limited resolution level. Typically, we can expect to image vessels with a diameter larger than 0.5 mm. Without a realistic simulation of the entire tree, we could not address the problem of the computation of the particles distribution on the existing set of terminal branches of the patient's vasculature. The goal of this work is to develop a model of the complete hepatic arterial vasculature, the most consistent with the patient's liver characteristics down to small capillaries, at least from a statistical point of view.
In Section 2.1, we will present the model used to simulate the patient-specific hepatic arterial network, to which we will refer as the "vascular model." This model, extensively described in [15] , can simulate the growth of the three liver vascular trees, based on a liver shape and on some initial vessels. In the present work, initialization of the vascular model is done with the segmented patient-specific data. Extraction of quantified data from the medical images is presented in Section 2.2. Since the images are acquired through different techniques, an important registration process is necessary to make the images compatible and to correctly initialize the model with the liver envelope and the main vessels. Section 3 presents the results of the segmentation and registration of hepatic arteries, liver, and tumors, as well as the global arterial tree obtained through the initialization of the vascular model with patient-specific data. We will also present a preliminary simplified simulation of microspheres distribution in the simulated arterial tree and quantification of their deposition in the tissues. Section 4 shows the clinical applications and the future work needed before the physicians could actually implement it in their protocol: a numerical model of the geometry of the vessels is needed for a complete and realistic simulation and analysis of the blood flow inside the liver. This, in turn, permits a more accurate simulation of microspheres transport by blood and of their trajectories through the vessels. The estimation of microspheres distribution in the liver is crucial for the administration of SIRT. We will present the principal conclusions of this work in Section 5.
Clinical context
The liver is the largest internal organ of the human body and its role is crucial for metabolism. Blood is supplied by two different paths: portal vein furnishes around 75% of it, while the remaining 25% is provided by the hepatic artery, which brings oxygenated blood directly from the aorta [7] .
A particularity of HCC is that it is almost exclusively vascularized by the hepatic artery. This characteristic allows the physician to reach the tumor with a catheter inserted into the femoral artery, guided through the aorta and then directly into the hepatic artery. Moreover, a tumor stimulates the generation of vessels to have access to nutrients. This angiogenic process is pathological, and it results in a disordered and dense network with a high fractal dimension [16] . This arterial hypervascularization of HCC is the reason why the arterial blood flow within the tumor is 3 to 7 times greater than in the surrounding noncancerous tissue. This means that it is legitimate to hope that some therapeutic agent injected in the arterial tree will be more concentrated in the tumor than in the healthy tissue. This leads the way to a variety of therapies that have improved during the last decades: injection of chemotherapeutic agents, radio-labeled particles, or even non-reactive particles, with the only aim of embolization.
The gold standard for treating intermediate stage HCC is now considered trans-arterial chemo embolization (TACE) [22] . This approach appears to confer some palliative benefit to many patients, but post embolization syndrome can be severe after TACE.
An alternative is represented by trans-arterial radio embolization (TARE), which is a way to deliver selectively high radiation dose in the area of interest of the liver with far less embolizing characteristics than TACE [1] . SIRT falls within this framework. The most frequently reported agents available for TARE are 131 I radio-labelled lipiodol and Yttrium-90 loaded microspheres [1] . The first one is strongly limited by the emission of high-energy gamma radiation. The latter was developed recently to avoid radioprotection problems, Yttrium-90 being a pure beta rays emitter [19] . Globally, TARE gives equivalent results than TACE for intermediate stage HCC and it presents fewer side effects. For end-stage HCC, TARE therapies are found to have even a better outcome than TACE [1] .
SIRT can be delivered through two different kinds of microspheres: SIR-Spheres ® (SIRTeX Medical Limited, Australia) and Theraspheres ® (BTG, UK). Our interest concerns Therasphere ® , which have a smaller diameter, around 25 μm, and are made of glass. Their activity is 50 times greater than SIR-spheres ® [19] and they do not appear to have embolization effects. Thus, Therasphere ® do not prevent the administration of following therapies through the same path.
The current protocol for the treatment of HCC includes a first computed tomography (CT) to identify and locate the malignancies. Nowadays, the use of MRI is also increasing thanks to its less invasive nature. Both imaging modalities are performed with contrast agents and at different phases of its distribution within the vasculature. These acquisitions allow a proper evaluation of extent of the tumor, help the radiologist to guide the angiography, and are a baseline reference to assessment of response.
The administration of SIRT requires of course a good knowledge of the arterial tree's branches and bifurcations. For this purpose an arteriography is realized through the injection in the liver arteries of an iodine-based contrast media and the consecutive acquisition of a 3D rotational Cone Beam CT (Fig.1) .
This acquisition gives a detailed portrait of the arterial tree and allows the interventional radiologist to choose the injection point for future delivery of the treatment. This choice is made by the radiologist without any kind of technological help, making it unreproducible and subject to human error. The hepatic vasculature is very complex and sometimes tortuous, currently it is impossible to have a precise knowledge of it. The choice of this point is currently validated by the injection of a particular kind of proteins, which are likely to imitate the behavior of the microspheres in the blood transport phenomenon. Their distribution is captured by a SPECT-CT acquisition (singlephoton emission computed tomography, coupled to CT). One to two weeks after this diagnostic arteriography, the therapeutic arteriography delivers the microspheres loaded with 90 Y, and another SPECT-CT is acquired. Efficacy is finally assessed by morphologic imaging (either MRI or CT) performed every 2 to 3 months.
Methods
In order to simulate a patient-specific hepatic arterial tree, it is necessary to extract as accurately as possible information from the patient's data. As shown in Fig. 2 , we first segment the profile of the liver with tumors from CT at portal phase, whereas hepatic arteries are segmented from 3D Cone Beam CT angiography. After a registration process between the two segmented volumes, we can launch the vascular model previously developed [13, 15] .
The computational model described in [13] is able to simulate the liver vascular trees [15] in normal or some pathological situations [18] . This model allows the user to simulate the growth of the hepatic arteries, the portal vein and the hepatic veins, after an initialization phase where the patient specific main vessels can be introduced. The model also requires the contour of the shape of the liver and, if any, the areas where a malignancy is present. Thanks to this information, the model can start growing the smaller vessels. It extends and develops the input vessels, in order to irrigate all the tissue of the liver. When a malignancy is present, the vasculature growth will be denser and more irregular. The necrotic tissue can also be simulated by a decrease of the vascularization until total vanishing of the vessels. The criteria regulating the vessels growth will be given in Section 2.1. Information about liver shape, location and dimension of malignancies, as well as the geometry of the main hepatic arteries can be extracted from the images available in the context of the protocol. This will be presented in Section 2.2.
Vascular model
The model creates a vascular network that can be made of one or more vascular trees. A vascular tree is composed of vessels that can divide creating bifurcations (Fig. 3) . Each vessel segment (the part of the vessel between two successive bifurcations) is represented as an ideal, rigid tube with fixed radius, wall thickness, length and position. Based on Fig. 2 Outline of the method used to simulate the patient-specific hepatic arterial tree. In order to initialize the model, segmentation of liver with tumors (from portal phase CT) and arteries (from angiography) are needed morphometrical investigation [27] , it is assumed that the vascular tree is a binary tree.
Simulation of vascular growth
The simulation [15] is initialized by a limited vascular network, consisting of a few vessel segments based for example on standard anatomical data or patient-specific segmented images. Further development of vascular trees is modeled as an analogy to a hyperplasia process (an increase in the amount of tissue). The increasing needs of the growing tissue induce the development of the vascular network which is responsible for blood delivery.
Tissue is represented by a set of macro-cells that are regularly (but randomly) distributed inside the predefined 3D shape (Fig. 3b) . A macro-cell corresponds to a small part of the tissue, including mainly capillaries, with a predefined average size, defined for healthy macro-cells as 0.125 cm 3 . The need of each macro-cell for blood is defined by its class (healthy, cancerous, necrotic, ...), which determines most of its structural and functional properties (e.g., size, birth/death probability), as well as physiological features (e.g., blood pressure, blood flow rate). For example, tumor macro-cells have a higher birth probability than the healthy ones, and their spatial density is higher. Moreover, different classes allow various pathological changes to be investigated. Some of the macro-cell features are described by statistical distributions in order to introduce a natural variability. The geometry of the smallest vessels, i.e., capillaries, is not considered as they are hidden in the macro-cells. As a result, anastomoses (mutual vessel intersections) that occur mainly among vessels with very small radii are not taken into account.
The algorithm of vascular development is divided in cycles. In consecutive cycles, each macro-cell can divide and give birth to a new macro-cell or die (analogy to mitosis and necrosis processes). The algorithm is initialized with an initial set of macro-cells, placed at every end of the initial tree. The newly appeared macro-cells are initially not supplied by the existing vascular network. Thus, the procedure of sprouting new vessels towards the new macro-cell is performed. Several candidate bifurcations, constrained by a maximal distance from the macro-cell, are created. Based on them, temporary vascular structures appear. This process can be considered as a kind of competition, since only one vessel (with the lowest sum of volumes, local minimization) is finally chosen as the permanent one. Afterwards, the characteristics of the vessels (i.e., blood flow, pressure etc.) are recalculated to fulfill all the used physical constraints.
At every bifurcation, two physical constraints are in effect. The first one deals with the decreasing vessel radii in the vascular tree, creating a relationship between the radius of a father vessel and the radii of its two descendants [14] .
Second, the matter conservation law must be observed at each bifurcation: the physical quantities of blood entering and leaving a bifurcation must be identical. Blood flow is modeled in a simplified manner. It is considered as a Newtonian (with constant viscosity μ), incompressible fluid, and its flow is governed by the Poiseuille's law, which relates the pressure difference between the two extremities of a vessel segment ( P ) to its blood flow rate (Q), length (l) and radius (r):
The growth of a tumor region always corresponds to an increase of the total hepatic blood flow [8] . The capillary network is denser even inside the lobules, the elementary components of the liver. In the model, tumor macro-cells and vasculature are defined through three principal characteristics. First, blood flow at the entrance of tumor macrocells was defined as 3 times higher than in the healthy tissue. This ratio is usually considered to be at least 2 in the literature, but can be much higher [2] . Second, the ratio between birth and death probability of tumor macro-cells was higher than in healthy macro-cells. Last, a denser vascular network was induced through an increase of the spatial density of macro-cells to be irrigated. This is done by authorizing a smaller distance between a newly born macro-cell and the already existing ones [15] . In this way, the number of macrocells in a same region is higher, and the size of macro-cells is thus implicitly reduced.
Since no information about hepatic arterial pressure is available for those patients, pressure value at the entrance of hepatic artery was taken from the literature [7] . Pressure value at macro-cells level was deduced from the diagram relying blood pressure to vessels diameter in human systemic circuit [17] . We consider that pressure values do not depend on the nature of the tissue (tumor or healthy) and on the patient. The initial parameters for the simulation of the vascular network are given in Table 1 . At the algorithm initialization, the macro-cells pressure is the one given in Table  1 . Such values are conserved for the surviving macro-cells. Moreover, such same value is assigned to every newborn macro-cell. Therefore, at the end of the tree growth, this Initial number of macro-cells corresponds to the number of extremities of the segmented arterial tree pressure value is conserved and is constant on the final set of macro-cells. The different characteristics of the initial tree for the two patients derive from the arterial tree segmentation step, as will be clarified in Section 3.1.
Simulation of microspheres distribution
Recent improvements of the model allow more realistic simulation of liver functionalities, in the aim of SIRT modeling. Preliminary simulations of the choice of microspheres best injection point in the arterial tree can be performed. It is temporarily assumed that microspheres flow in every vessel situated downstream from the injection point, proportionally to the blood flow given by Poiseuille's law. Indeed, an intrinsic property of the vascular model is the notion of blood flow, given by Poiseuile's law, in every vessel and in every macro-cell of the vascular tree. This property easily allows us to quantify dose distribution in every tissue macro-cell. Namely, starting from any injection point in the tree, at every bifurcation met, the dose will be distributed proportionally to the blood flow of the two child vessels. Therefore, we can compute, based on any chosen injection point, the percentage of the injected activity which reached every healthy or tumor macro-cell. Let us now define N h as the total number of macro-cells representing the healthy liver, and N t as the total number of macro-cells representing the tumor. In the same way, we defineN h as the number of healthy macro-cells reached by the microspheres, and N t as the equivalent for the tumor macro-cells. For every macro-cell i, we define the injected activity reaching such macro-cell i as:
where A is the total injected activity, q i is the flow rate at the entrance of the macro-cell i, and Q p is the flow rate at the injection point p. Consequently, we can compute the injected activity that reaches all the healthy tissues by:
where I h is the index set of healthy macro-cells, and the injected activity reaching the tumor as:
where I t is the index set of macro-cells of the tumor. The percentage of the injected activity to the healthy tissues and to the tumor are finally computed as:
We can also compute the percentages of the healthy and tumor volumes that are irradiated. The percentage of healthy tissue that is reached by the microspheres is given by:
where the indicator function 1 A i >0 is equal to 1 when the activity A i of the macro-cell i is strictly positive and 0 otherwise. Respectively, the percentage of treated tumor volume is:
In conclusion, we can compute how much of the injected activity reaches how much of the tumor/healthy tissues. We developed an interactive software that allows the user to navigate through the tree bifurcations, while an interface continuously shows the percentage of the activity distributed in tumor and healthy tissue, φ h and φ t , as well as the percentages of irradiated volumes T h and T t .
Images processing
Image analysis for the extraction of patient specific anatomical data can improve all the major steps of the clinical protocol as hepatopulmonary shunt estimation, dosimetry and response evaluation. In this work, we focus on segmentation of hepatic arteries and shape of liver and malignancies, necessary to initialize the vascular model. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments. Approval by the institutional Medical Ethics Review Board and proper informed consent were obtained.
Vessels segmentation
An extended arteries segmentation can be performed on 3D Cone-Beam CT angiography. Thanks to iodine-based contrast agent, the vessels are highly visible, as shown in Fig. 1 . Bibliographic study about vessels segmentation showed no algorithm to automatically reconstruct the tree structure Fig. 4 Example of semi-automatic segmentation of vessels with EndoSize. At each step the user defines a new point inside the vessels from hepatic vascular network [3, 6, 25] . The arteries are then semi-manually segmented by using EndoSize© software (Therenva SAS, Rennes, France). Since this software was originally conceived for the aortic trunk, the segmentation can not be completely automatic, the structure of the hepatic arterial tree being more complex. Every vessel of the arterial tree is identified by some critical points manually chosen (Fig. 4) .
The 3D coordinates of every selected point are then automatically saved in a format able to reestablish the binary tree structure of the vessels (tree root, children vessels, tree leaves) needed for the initialization of the simulation in the vascular model. We also measure the diameters of every vessel segment with EndoSize software.
Liver shape segmentation
Segmentation of liver and malignancies is performed on full-torso portal phase CT scans by using the MESA software [24] , developed at Bialystok University of Technology. MESA is a platform for design and evaluation of segmentation methods and provides tools for management and visualization of medical images. The shape of the liver is extracted with a built-in semi-automatic active surface method [23] that performs a fast fully 3D segmentation of the volume and requires only small manual corrections. The active surface model is represented as a deformable polygon mesh that evolves under the influence of external image features and internal constraints (Fig. 5) .
Final results can require some manual corrections, especially near the vessels, performed with a 2D paintbrush-like tool integrated in MESA software. Concerning tumors segmentation, being the malignancies borders less neat, they are segmented with an active contour model on 2D slices, which requires major manual corrections. The final results are exported to a format readable by the vascular simulation model.
Liver volume is separately measured on a Siemens radiologist workstation, with the vendor supplied application "Volumétrie" in order to validate segmentation.
3D multimodal liver registration
Unfortunately, there is no available image where satisfactory segmentation of liver shape and vessels can both be realized in a common reference system. In fact, 3D conebeam CT angiography is acquired when contrast agent reaches hepatic arteries, and is still not spread in all the liver tissue (arterial phase). For this reason, liver contour is hardly detectable (Fig. 6a) in 3D angiography.
Other images are available, among which two CT acquisitions. The first one at arterial phase (Fig. 6b) , when the contrast agent is only in the arteries, and the second one at portal phase (Fig. 6c) , i.e., when contrast agent [23] reaches the liver through the portal vein (a few seconds later than through the hepatic artery). Figure 6b shows that the biggest vessels of hepatic arterial tree are visible on this kind of acquisition (white arrow) and that they can be segmented. However, the best segmentation of liver shape can be achieved on the portal phase volume, when all liver parenchyma is enhanced (Fig. 6c) . This leads to the need of a registration process, outlined in Fig. 7 , to match information issued from different acquisitions.
Image dimensions are different for every acquisition. Moreover, angiography is acquired 1 or 2 weeks after CT. Since the liver moves to adapt to body changes, the two images are inevitably different. Furthermore, between the two acquisitions, Patient 1 was subjected to an extra-hepatic artery coil embolization. Namely, a coil was guided to the artery through a catheter and deployed in the chosen vessel with the aim of occluding it. This inevitably induced some artifacts in the resulting cone-beam CT (Fig. 6a) .
As shown in Fig. 7 , the chosen reference volume for registration is portal phase CT. Direct registration from angiography to portal CT is not possible due to the absence of any similar and common information on the two acquisitions: hepatic arteries almost do not appear on portal CT and liver contour is hardly visible on angiography. This is why we employ arterial phase CT to perform an intermediate step in registration: indeed, this acquisition gives a satisfactory representation of both liver contour and principal hepatic arteries.
Two steps are then identified ( Fig. 7) : first arterial phase CT is registered on portal phase CT (Fig. 6b-c) , next principal hepatic arteries allow registration of angiography on arterial phase CT (Fig. 6a-b) . A quick comparison between Fig. 6b, c shows that the first step is straightforward. Indeed, images are acquired during the same examination, the difference lying in the acquisition time during contrast agent propagation and in the choice of acquisition parameters. We accomplish this step through a rigid transformation identified automatically by a multimodal registration algorithm based on mutual information metric [21] . Registration is verified qualitatively through a checkerboard volume.
Registration of angiography on arterial phase CT is based on principal arteries geometry. We draw on both images a region of interest in order to select the biggest hepatic arteries, which are clearly visible even on arterial CT. Vessels' enhancement on both arterial phase CT and angiography is then realized applying a 3D multiscale Frangi's filter [9, 12] . The algorithm uses the eigenvalues (λ 1 λ 2 λ 3 ) of the Hessian matrix of a Mexican hat kernel smoothed version of the image. Such eigenvalues characterize the tubular shape of the vessels and are used to compute a "vesselness function" which is zero if λ 2 > 0 or λ 3 > 0, and otherwise is defined as:
where Defined parameters are shown in Table 2 . We identified a set of parameters convenient for both patients. Next to the Frangi's filter, a grayscale threshold is applied on both images in order to completely remove every non vascular structure. Last, a 3D erosion is applied on angiography in order to simplify the geometry and remove unnecessary information absent on arterial CT. Images are finally registered through an affine transformation (translation, rotation and scaling). The transformation matrix is automatically calculated by a multimodal registration algorithm, based on mutual information metric [21] . The algorithm optimizes images similarity through an iterative evolutionary algorithm [26] for which we identified a set of suitable parameters. Images resolution can be given to the algorithm in order to identify scaling coefficients, ameliorate results and reduce computational time.
Registration is validated through a visual comparison and superimposition of Frangi's enhanced angiography and arterial phase CT. For further validation, we apply the transformation to original angiography and visually compare it to original arterial CT. The identified series of geometrical transformations is finally applied to the list of points describing the arteries, segmented from 3D angiography in EndoSize. Transformation 2 (Fig. 7) registers points to arterial CT, and next transformation 1 is applied to register them to portal CT, where tumors and liver are segmented. 
Results
In order to prepare the initialization of the vascular model, we collect all the needed patients' information in a coherent way. In the present study, we applied the described method to the CT volumes of two patients.
Image processing results
Results concerning arteries segmentation with EndoSize are shown in Fig. 8 . The number of leaves of the arterial tree is 39 for Patient 1 and 19 for the other one, as shown in Table 1 . 3 , whereas the volume measured on the Siemens radiologist workstation is 1410 cm 3 . For patient 2, the volume of segmented liver is 2650 cm 3 , the volume measured by the "Volumétrie" application being 2486 cm 3 . Segmentation results are shown in Fig. 9 .
Registration of arterial phase CT on portal phase CT (1 • Registration in Fig. 7) is shown in Fig. 10 through a checkerboard volume. Figure 11a shows the registration of Frangi's enhanced images of angiography to arterial phase CT (2 • Registration in Fig.7) . The result of registration transformation applied on original angiography is shown in Fig. 11 , superimposed to original arterial phase CT. Finally, a 3D visual representation of the input data employed in the vascular model (liver, tumor and arteries) is given in Fig. 12. 
Vascular model results
We can then launch the vascular model with the patientspecific data. The model was launched on a portable computer equipped with Intel Core i7 CPU (2.3 GHz) and 16 GB of RAM under OS X Yosemite. Computational time for the growth of the entire tree is ∼10 min, depending on liver size. The radii of the simulated vessels for Patient 1 vary between Simulated hepatic arterial trees are shown in Fig. 13 . In Fig. 13a only the vessels whose radius is higher than 0.4 mm are visualized. Comparison to Fig. 12 shows that the original shape of segmented vessels, used for the vascular model initialization, is preserved during the simulation of the arterial tree growth. Tumor vasculature was denser than in the healthy tissue due to the higher authorized density of macro-cells in this region.
Application to microspheres distribution in liver
Since our final aim is to simulate the injection of Theraspheres, we analyze their distribution under simplifying hypotheses, i.e., we simulate microspheres distribution as to be proportional to blood flow given by Poiseuille's law. Under such assumptions we are able to compute, depending on catheter tip placement, the percentage of injected healthy and tumor tissue (T h and T t ), as well as the percentage of the injected dose which deposits in healthy and tumor liver (φ h and φ t ). As shown in Fig. 14 , we can propose an optimal injection point specific to every patient. Many patient-specific factors play an important role in the choice of the optimal point. In the current work, optimization refers to a cost function depending only on injected healthy and tumor tissues percentages.
The point suggested in Fig. 14a (left) for Patient 1 induces radiations to 71% of the tumor (T t = 71) and to 3% of the healthy liver (T h = 3). The optimal catheter tip Fig. 14b (left) : we calculated that 64% of the tumor is injected (T t = 64), together with 2% of healthy tissue (T h = 2). Right images of Fig. 14a, b show respectively the distribution of microspheres if the catheter tip is placed at the root of the arterial tree. In this case, all the tissue is irradiated, but a stronger concentration of radiations can be noticed in tumor cells. We quantified that in this scenario 9.2% of the injected radioactivity deposits in the tumor for Patient 1 (φ t = 9.2) and 27.8% for Patient 2 (φ t = 27.8). This preponderance of microspheres in the tumor can be explained by two reasons: tumor macro-cells are more demanding in blood Fig. 12 Registration results between CT and 3D angiography for both patients. Superimposition of liver and tumor contours obtained from portal phase CT and vascular skeleton segmented from angiography flow, and vascularization is denser within the tumor. Even if we decided to compare only two injection points for one patient, our model allows the user to easily navigate into the vascular tree while calculating in real time the percentages of dose distribution mentioned above. This appears to be a promising approach in quantification of dose distribution in liver, with the aim of injection mode optimization.
Validation of microspheres injection simulation
In order to estimate the validity of the simulation, we considered the SPECT/CT realized on Patient 2 after the diagnostic and therapeutic angiographies. Table 3 shows the percentage φ t of the injected radioactivity that deposits to the tumor.
The table compares the values given by the simulation to the measurements clinically realized by an experienced nuclear radiologist at "Eugène Marquis Centre (CEM) for the fight against Cancer," Rennes, France, according to the method described in [10] . In both cases and for both patients, catheter tip was placed at the root of the tree, therefore all the healthy and tumor tissues were irradiated (T h = T t = 100). The discrepancy concerning the distribution for Patient 2 can be justified by multiple reasons. First, In the right image, catheter tip is positioned at the root of the arterial tree (point P 2 , for which T h = T t = 100). b Similarly for Patient 2, an optimal catheter tip position (P 1 ) is proposed in the left image: 64% of the tumor and 2% of healthy tissue are injected (T t = 64 and T h = 2). In the right image, catheter tip is positioned at the root of the arterial tree (point P 2 , for which T h = T t = 100) the patient presents several small tumor regions which were not segmented, and therefore not simulated, in this study. Second, the patient underwent a left lobe hepatectomy, which causes radiations deposition in the tissues neighboring the resection. Furthermore, clinical measurements were acquired through the "volumetric analysis" software (Syngo workstation; Siemens), that performs tumors segmentation using a threshold applied to radiations intensity [10] . This can lead to a biased computation of tumor volume, in particular to an overestimation due to extra-tumor radiations deposition. Figure 15 shows a comparison between the SPECT/CT and the microspheres distribution simulation for the same patient. It can be observed that in both images microspheres concentration in tumor tissue is higher. This is due to the greater need of blood, characteristic of tumors, and to the dense and tortuous architecture of tumor blood vessels. It should be noticed that, in this case study, radiologist chose were injected at the root of arterial tree, therefore T t = T h = 100 .
Blue-yellow colormap gives the percentage φ t of microspheres in the injected tissue to inject at the root of the tree due to the presence of multiple tumors and a cirrhotic tissue, characteristics that were not taken into account in this work. Moreover, a precise comparison of liver shape could not be achieved due to the nature of the two images. Indeed, SPECT/CT is composed of a stack of slices of the hepatic volume, whereas our model offers a 3D visualization of the volume.
Discussion
We can generate a hepatic arterial tree that mimics the contour and function of the patient's vasculature. This process requires segmentation of the shape of liver, tumors, and biggest and more visible hepatic arteries. An important registration process between the two segmented volumes is needed before the vascular model can be initialized. We developed an automatic procedure to register cone-beam CT angiography to CT volume. This includes vessels enhancement by Frangi's algorithm. The choice of the Frangi's parameters being relevant, we identified a set of parameters for each modality that appears to be suitable for any patients. In fact, the geometrical characteristics of the vessels (size, brightness) that Frangi's algorithm calculates do not depend on the patient but only on image modality. For the same reasons, we can deduce the stability of the parameters identified for the optimization algorithm used for registration.
Initial pressure values at the entrance of the hepatic arteries, as well as more deeply in the arterial tree, needed for the initialization of the vascular model, are determined from literature. In the future, we plan to measure it at different levels of the hepatic arterial tree, thanks to a micro catheter.
Results show good correspondence between real and in silico arterial trees. Nevertheless, some differences appear between the segmented arteries used to initialize the model (Fig. 12) , and the principal simulated ones (Fig. 13a) . This phenomenon shows the importance of finding a compromise between two constraints: first, to preserve the segmented vessels during the simulation; second, the possibility to modify them during the growth of the arterial tree, in order to verify the optimization constraints defined in the model when creating new bifurcations. Future improvements of the model will take into account the first constraint more strictly, as well as the peculiarities of the vasculature due to different pathologies, e.g. vessels tortuosity or arteriovenous shunt. Future work will also concentrate on automatization of hepatic arteries segmentation, and will aim at concrete applicability of this model in actual SIRT protocol.
We are aware that the simulated part of the arterial tree represents the real one only from a statistical point of view. Nevertheless, numerical simulation of microspheres transport and deposition still leads to a statistically realistic microspheres distribution map in the liver tissue, useful in clinical routine. A mean dose distribution map can be estimated by a kernel smoothing of the discrete distribution corresponding to the microspheres centers scatterplot. Moreover, such estimated dose distribution map will be nearly invariant to random changes of microspheres positions, as long as their statistical spatial distribution is preserved.
In order to better take into account liver functionalities, we will focus on the simulation of the blood flow and of microspheres trajectories simulation. It was noted [4] that microspheres transport could not be deduced directly from flow computation. The workflow we proposed here will be improved by recomputing flow and microspheres transport more accurately with computational fluid dynamics (CFD). Two kinds of simulation could be considered: a precise CFD simulation of particles trajectories down to the smallest vessels where a realistic mesh can be defined, and a simplified spheres distribution quantification as the one proposed in this paper.
Simulation of the complete arterial tree has two more interests. First, pressure values given by Poiseuille's law at every level of the simulated tree can be used in order to initialize the pressure boundary conditions necessaries for the CFD simulations. Moreover, it can be used in order to perform a sensitivity study of blood flow, depending on boundary conditions on downstream vessels. Indeed, such conditions are known to be one of the principal difficulties in physiologically based CFD [20] . We plan to deal with complex and large vascular structures, like those presented in this work, that will let us realize a sensitivity study of dose distribution, depending on catheter tip positioning.
Conclusion
We developed a new procedure for patient-specific hepatic arterial tree modeling, down to arterioles with a diameter of ∼0.05 mm. Our model is also able to provide the chaotic and dense vascularization typical of tumors. Simulations are based on the analysis of medical images, from which we segment, and register, patient's hepatic arteries, liver and tumors. We provide a preliminary simulation of microspheres injection and a quantification of their distribution in tumor and healthy tissue, down to small arterioles, based on the Poiseuille's law. The current model is still preliminary and does not differentiate between the behavior of glass microspheres and of the proteins injected during the diagnostic angiography. Nevertheless, it represents an important tool for the initialization of more precise CFD simulations, and it opens the way towards a personalized, quantitative model of SIRT, that will require rigid validations.
